Interventional Cardiology :: Nationwide Children's Hospital

Interventional Cardiology Congress of Latin America

Nationwide Children's Hospital performed a live case of a Melody TPV implant in Brazil in July 2013.

Read more about this international event »

Make a Referral

Featured Physician: Dr. John Cheatham

Interventional Cardiology

Interventional cardiology is an internally recognized program that provides a full spectrum of diagnostic and interventional cardiac catheterization procedures. We offer state-of-the-art technology including two custom-built Hybrid Cardiac Catheterization Suites and a Hybrid Operating Suite equipped to provide for the interventional treatment of all patients (from a 700g premature infant to an 80-year-old adult) with congenital and acquired heart disease. This includes interventional transcatheter therapy of adults with congenital or structural heart disease.

We believe quality and safety are top priorities. Our program participates in national and international quality improvement efforts including:

  • Congenital Cardiac Catheterization Outcomes Project (C3PO) Registry

  • Mid-Atlantic Group of Interventional Cardiology (MAGIC) Registry

  • Improving Pediatric and Adult Congenital Treatment (IMPACT) working group of the Adult Congenital and Pediatric Cardiology (ACPC) Section Member

Interventional cardiology is truly the future of heart care for children and adults, allowing complex procedures to be successfully completed while leaving the patient with a band-aid, rather than a scar. At Nationwide Children's, the full range of interventional cardiology procedures is available:

  • Balloon dilation of stenotic valves or narrowed vessels

  • Catheterization

  • Coil embolization of undesirable vessels and patent ductus

  • Radiofrequency and Cryogenic catheter ablation of accessory conduction pathways

  • Stenting of narrowed vessels

Dramatic improvements in interventional cardiac catheterization treatments and techniques allow specialists to care for more and more cardiac problems without surgery. Our cardiac interventionists are among the best in the world, pioneering treatments right here at Nationwide Children's. This innovative spirit has led to a collaborative interventional catheterization and cardiothoracic surgery program, causing the lines between transcatheter and surgical treatment strategies to blur. Thus, The Heart Center’s need for a therapeutic suite that is compatible with both interventional cardiology and cardiothoracic surgery – learn more about our one-of-a-kind Hybrid Cardiac Suites.

Interventional Cardiology Expertise in:

  • Staged hybrid therapy of patients with hypoplastic left heart syndrome

  • Expanding hybrid and intraoperative interventional procedures and new therapeutic strategies

  • Transcatheter implantation of the pulmonary valve

  • Closure of atrial and ventricular septal defects

  • Closure of patent ductus arteriosus (including infants weighing less than 5kg)

  • Treatment of patients with complex pulmonary artery obstructions

  • Treatment of patients with coarctation of the aorta and complex arch obstructions

  • Interventional catheterization procedures in very premature infants 


 

The Heart Center had a key role in the FDA approval of the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System as well as with the development of both the stent and balloon-in-balloon products. This new treatment is the first in the United States offering minimally-invasive treatment options for congenital heart disease patients. This will help minimize and delay the need for multiple open heart surgeries over a patient's lifetime. Nationwide Children's was one of five initial clinical trial locations.

Nationwide Children's Stent Development Lays Groundwork for Melody Valve

The Heart Center had a key role in the FDA approval of the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System as well as with the development of both the stent and balloon-in-balloon products. This new treatment is the first in the United States offering minimally-invasive treatment options for congenital heart disease patients. This will help minimize and delay the need for multiple open heart surgeries over a patient's lifetime. Nationwide Children's was one of five initial clinical trial locations.

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000